Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Assertio Therapeutics announces FDA complete response letter for long-acting cosyntropin

Oct. 22, 2019

University Hospital Heidelberg describes clinical testing of 18F-labeled FAPI tracer

Oct. 21, 2019

[68Ga]Ga-ProBOMB2 is a promising new GRPR-imaging PET radiotracer

Oct. 21, 2019

Novel minigastrin analogue for PET imaging of CCK2R-expressing tumors

Oct. 21, 2019

Novel albumin-binding agents for FAP-targeted radionuclide therapy presented

Oct. 18, 2019

Synthesis and characterization of novel N-carboxymethyl-substituted PSMA ligands

Oct. 18, 2019

Bioevaluation of novel TSPO-selective PET probe, [18F]BS-224

Oct. 18, 2019

First-in-human data presented for [99mTc]-ADAPT6

Oct. 18, 2019

18F-Labeled PSMA ligand development leads to clinical candidate [18F]siPSMA-14

Oct. 18, 2019

[68Ga]Ga-DO3A-S01-GCG: a first-in-class GCGR PET tracer with proof of concept in preclinical phase

Oct. 17, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...